Literature DB >> 2466366

Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.

J A Cowley1, B M Gorman.   

Abstract

Genetic reassortment studies of bluetongue virus (BTV) Types 20 and 21 have revealed a reassortant genotype that was not neutralized serotype-specifically. In reciprocal neutralization tests, BTV 20 and 21 were neutralized specifically by homologous antiserum. Similarly, reassortants that possessed both outer capsid proteins (i.e., VP2 and VP5) from the same parent virus reacted with that antiserum specifically. However, two reassortants, 16(9) and 19(1), with VP2 of BTV 20 and VP5 of BTV 21 had intermediate neutralization characteristics. These reassortants were neutralized to high titres by antiserum to BTV 20 and to lower, but significant titres by antiserum to BTV 21. In addition, antiserum to BTV 20 induced 10-16-fold higher titres in plaque reduction neutralization (PRN) tests with these two reassortants compared with BTV 20 itself. Evidence of the serological cross-reactivity of Reassortants 16(9) and 19(1) was also found with respect to reductions in plaque sizes observed in the PRN tests. The average plaque sizes of these reassortants were reduced to differing extents by antiserum to BTV 20 and 21, while those formed by the parent viruses were reduced in size by homologous antiserum only. Immunoblotting analysis of the structural proteins of BTV 20 and 21 demonstrated that VP2 alone was antigenically distinct, therefore confirming its role in determining serotype specificity in virus-neutralization tests. Electrophoretic analysis revealed considerable migrational differences between VP2 and VP5 of the parent viruses, suggesting that there was some divergence in their molecular weights, intrinsic charges or structural compositions. Taken together, the data suggest that the intermediate neutralization characteristics of the reassortants that contain VP2 and VP5 from different parent viruses are due to conformational alterations in their outer capsid structure which allow antibody recognition of common neutralizing epitopes that are not exposed on BTV 20 or BTV 21.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466366     DOI: 10.1016/0378-1135(89)90089-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  13 in total

1.  Heterologous expression of Bluetongue VP2 viral protein fragment in Pichia pastoris.

Authors:  T N Athmaram; Geetha Bali; Goon G Kahng; Sulatha Dwarakanath
Journal:  Virus Genes       Date:  2007-01-26       Impact factor: 2.332

2.  Association of bluetongue virus gene segment 5 with neuroinvasiveness.

Authors:  M A Carr; C C de Mattos; C A de Mattos; B I Osburn
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Differential serologic responses to reassortant bluetongue viruses recovered from a bull.

Authors:  M S Maia; B I Osburn
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Intragenic recombination as a mechanism of genetic diversity in bluetongue virus.

Authors:  Cheng-Qiang He; Nai-Zheng Ding; Mei He; Shan-Ni Li; Xing-Ming Wang; Hong-Bin He; Xin-Fa Liu; Hong-Shan Guo
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

5.  Genetic characterization of bluetongue virus serotype 9 isolates from India.

Authors:  Pavuluri Panduranga Rao; Y Vishnuvardhan Reddy; Keerti Meena; N Karunasree; B Susmitha; Madala Uma; P U V S Prasad; P Chaitanya; Y Narsimaha Reddy; Nagendra R Hegde
Journal:  Virus Genes       Date:  2012-01-19       Impact factor: 2.332

6.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

7.  A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A.

Authors:  Zhen Song; Changyuan Dong; Lulu Wang; Dong-E Chen; Guoming Bi; Ming Dai; Jun Liu
Journal:  Virol J       Date:  2010-06-13       Impact factor: 4.099

8.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

Review 9.  Adaptive strategies of African horse sickness virus to facilitate vector transmission.

Authors:  Anthony Wilson; Philip Scott Mellor; Camille Szmaragd; Peter Paul Clement Mertens
Journal:  Vet Res       Date:  2008-12-19       Impact factor: 3.683

10.  Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.

Authors:  Andrew E Shaw; Maxime Ratinier; Sandro Filipe Nunes; Kyriaki Nomikou; Marco Caporale; Matthew Golder; Kathryn Allan; Claude Hamers; Pascal Hudelet; Stéphan Zientara; Emmanuel Breard; Peter Mertens; Massimo Palmarini
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.